I was reading over an old post on the Swales protocol that included the following written by Swales:
"Any more than 500IU of HCG per day causes too much aromatase activity. Some feel aromatase is actually toxic to the Leydig cells of the testes. You are then inducing primary hypogonadism (which is permanent) while treating steroid-induced secondary (hypogonadotrophic) hypogonadism (which is temporary--hopefully)."
This got me thinking: Is it possible that cycles containing a high dose of test (which dramatically increasing aromatase activity) could cause Leydig toxicity and permanent hypogonadism? Would it make sense to use an AI on-cycle specifically for this reason?
It's scary to think that a test cycle could permanently damage the Leydig cells, but if Swales' statement is true then it suggests that this is possible (unless I'm missing something, which is also very possible).
Anybody have any more information on this?
"Any more than 500IU of HCG per day causes too much aromatase activity. Some feel aromatase is actually toxic to the Leydig cells of the testes. You are then inducing primary hypogonadism (which is permanent) while treating steroid-induced secondary (hypogonadotrophic) hypogonadism (which is temporary--hopefully)."
This got me thinking: Is it possible that cycles containing a high dose of test (which dramatically increasing aromatase activity) could cause Leydig toxicity and permanent hypogonadism? Would it make sense to use an AI on-cycle specifically for this reason?
It's scary to think that a test cycle could permanently damage the Leydig cells, but if Swales' statement is true then it suggests that this is possible (unless I'm missing something, which is also very possible).
Anybody have any more information on this?